Maravai Lifesciences Holdings(MRVI)
$7.54-0.14 (-1.82%)
MRVI
Maravai Lifesciences Holdings financials statements
$7.54
At close:-0.14 (-1.82%)
Want to see MRVI full AI Analyst Report?
Maravai Lifesciences Holdings (MRVI) Income Statement
425 Followers
Maravai Lifesciences Holdings Income Statement
Last quarter (Q3 2026), Maravai Lifesciences Holdings's total revenue was $45.85M, an increase of 10.14% from the same quarter last year. In Q3, Maravai Lifesciences Holdings's net income was $-13.84M. See Maravai Lifesciences Holdings’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 185.74M | $ 259.19M | $ 288.94M | $ 883.00M | $ 799.24M | |
| $ 33.39M | $ 108.31M | $ 140.20M | $ 714.04M | $ 658.68M | |
| $ 40.13M | $ 343.93M | $ 171.85M | $ 139.83M | $ 104.03M | |
| Depreciation and Amortization | $ 60.47M | $ 56.87M | $ 48.78M | $ 38.10M | $ 24.75M |
| $ -147.51M | $ -156.92M | $ 712.41M | $ 609.99M | $ 585.78M | |
| $ -6.74M | $ -235.62M | $ -31.65M | $ 574.22M | $ 554.64M | |
| $ -228.24M | $ -25.86M | $ 649.38M | $ -22.74M | $ -23.88M | |
| $ -234.97M | $ -261.48M | $ 617.74M | $ 551.47M | $ 530.76M | |
| $ -130.77M | $ -144.85M | $ -119.03M | $ 220.21M | $ 182.04M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.91 | $ -1.05 | $ -0.90 | $ 1.67 | $ 1.59 |
| Diluted EPS | $ -0.91 | $ -1.05 | $ -0.90 | $ 1.67 | $ 1.56 |
| Weighted Average Shares Outstanding | 145.07M | 137.91M | 131.92M | 131.54M | 114.79M |
| Weighted Average Shares Outstanding (Diluted) | 145.07M | 137.91M | 131.92M | 131.69M | 121.97M |
Currency in USD

